IOL Chemicals and Pharmaceuticals Limited (IOLCP) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, IOL Chemicals and Pharmaceuticals Limited (IOLCP) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs110.60 Million ≈ $1.20 Million USD) by net assets (Rs17.51 Billion ≈ $189.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check IOLCP capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

IOL Chemicals and Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how IOL Chemicals and Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. See net assets of IOL Chemicals and Pharmaceuticals Limite for net asset value and shareholders' equity analysis.

IOL Chemicals and Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of IOL Chemicals and Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
North American Financial 15
TO:FFN
0.060x
Premier Explosives Limited
NSE:PREMEXPLN
-0.262x
PureTech Health PLC
NASDAQ:PRTC
-0.126x
Benz Mining Corp
F:1VU
-0.404x
Rolex Rings Limited
NSE:ROLEXRINGS
0.075x
Ellaktor S.A
AT:ELLAKTOR
-0.004x
Beijing Hanyi Innovation Technology Co. Ltd. A
SHE:301270
N/A
Bajaj Electricals Limited
NSE:BAJAJELEC
0.113x

Annual Cash Flow Conversion Efficiency for IOL Chemicals and Pharmaceuticals Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of IOL Chemicals and Pharmaceuticals Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see IOL Chemicals and Pharmaceuticals Limite stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs16.88 Billion
≈ $182.51 Million
Rs1.79 Billion
≈ $19.32 Million
0.106x -41.20%
2024-03-31 Rs16.12 Billion
≈ $174.28 Million
Rs2.90 Billion
≈ $31.37 Million
0.180x +121.97%
2023-03-31 Rs15.08 Billion
≈ $163.05 Million
Rs1.22 Billion
≈ $13.22 Million
0.081x +21.34%
2022-03-31 Rs13.92 Billion
≈ $150.57 Million
Rs930.50 Million
≈ $10.06 Million
0.067x -77.82%
2021-03-31 Rs12.60 Billion
≈ $136.31 Million
Rs3.80 Billion
≈ $41.07 Million
0.301x -47.97%
2020-03-31 Rs8.14 Billion
≈ $87.98 Million
Rs4.71 Billion
≈ $50.95 Million
0.579x +0.55%
2019-03-31 Rs4.74 Billion
≈ $51.30 Million
Rs2.73 Billion
≈ $29.54 Million
0.576x +3.78%
2018-03-31 Rs2.16 Billion
≈ $23.33 Million
Rs1.20 Billion
≈ $12.95 Million
0.555x +25.65%
2017-03-31 Rs1.89 Billion
≈ $20.41 Million
Rs833.40 Million
≈ $9.01 Million
0.442x +370.45%
2016-03-31 Rs1.89 Billion
≈ $20.39 Million
Rs177.00 Million
≈ $1.91 Million
0.094x +141.42%
2015-03-31 Rs2.07 Billion
≈ $22.41 Million
Rs-469.60 Million
≈ $-5.08 Million
-0.227x -160.49%
2014-03-31 Rs2.09 Billion
≈ $22.63 Million
Rs784.02 Million
≈ $8.48 Million
0.375x +21.86%
2013-03-31 Rs1.73 Billion
≈ $18.71 Million
Rs531.92 Million
≈ $5.75 Million
0.307x -2.79%
2012-03-31 Rs1.74 Billion
≈ $18.77 Million
Rs549.11 Million
≈ $5.94 Million
0.316x +130.55%
2011-03-31 Rs1.72 Billion
≈ $18.64 Million
Rs236.44 Million
≈ $2.56 Million
0.137x -35.32%
2010-03-31 Rs1.48 Billion
≈ $16.02 Million
Rs314.24 Million
≈ $3.40 Million
0.212x +24.13%
2009-03-31 Rs1.26 Billion
≈ $13.58 Million
Rs214.51 Million
≈ $2.32 Million
0.171x -35.12%
2008-03-31 Rs849.06 Million
≈ $9.18 Million
Rs223.61 Million
≈ $2.42 Million
0.263x -43.53%
2007-03-31 Rs330.31 Million
≈ $3.57 Million
Rs154.06 Million
≈ $1.67 Million
0.466x +24.89%
2006-03-31 Rs185.50 Million
≈ $2.01 Million
Rs69.28 Million
≈ $749.20K
0.373x +175.94%
2005-03-31 Rs105.23 Million
≈ $1.14 Million
Rs14.24 Million
≈ $154.01K
0.135x --

About IOL Chemicals and Pharmaceuticals Limited

NSE:IOLCP India Drug Manufacturers - Specialty & Generic
Market Cap
$417.11 Million
Rs38.57 Billion INR
Market Cap Rank
#13462 Global
#644 in India
Share Price
Rs131.40
Change (1 day)
-3.42%
52-Week Range
Rs68.21 - Rs136.06
All Time High
Rs840.03
About

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, pa… Read more